The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
[引用][C] The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - The Lancet …, 2015 - cir.nii.ac.jp
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic
tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted …
tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted …
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - The Lancet …, 2015 - Elsevier
Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, JL Lee, BI Rini, JJ Knox… - Lancet …, 2015 - pure.au.dk
BACKGROUND: Previous prognostic models for second-line systemic therapy in patients
with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy …
with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy …
[PDF][PDF] The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - 2015 - academia.edu
Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - 2015 - ir.ymlib.yonsei.ac.kr
BACKGROUND: Previous prognostic models for second-line systemic therapy in patients
with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy …
with metastatic renal cell carcinoma have not been studied in the setting of targeted therapy …
[PDF][PDF] The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - Lancet …, 2015 - researchgate.net
Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
The international metastatic renal cell carcinoma database consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, J lyun Lee… - The Lancet …, 2015 - yonsei.elsevierpure.com
Background: Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, JL Lee, BI Rini… - The Lancet …, 2015 - europepmc.org
Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox… - The Lancet …, 2015 - infona.pl
Previous prognostic models for second-line systemic therapy in patients with metastatic
renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to …
renal cell carcinoma have not been studied in the setting of targeted therapy. We sought to …